Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
\"alligator bioscience\"
-
search results
If you're not happy with the results, please do another search
BioStock at Swiss Nordic Bio 2025
17 March, 2025
Alligator’s CEO: “We are not surprised by the positive readout”
3 March, 2025
BioStock Investor Pitch: Alligator Bioscience
3 February, 2025
Alligator’s CEO: “I’m confident that we will strike a deal”
30 January, 2025
Alligator’s CEO: “We are on track to secure a partnership”
10 December, 2024
Robust data drives Alligator Bioscience forward
30 October, 2024
Alligator brings in new CFO ahead of phase III
3 September, 2024
“Unprecedented” phase II data for Alligator in pancreatic cancer
3 July, 2024
Alligator’s mitazalimab data published in The Lancet Oncology
4 June, 2024
Orion option exercise triggers milestone payment for Alligator
2 May, 2024
Alligator Bioscience on the importance of prolonging life
2 April, 2024
WntResearch’s new CEO comments on his first month in the position
27 March, 2024
Alligator to maximise immuno-oncology innovation
27 March, 2024
BioStock Investor Pitch: Alligator Bioscience
25 March, 2024
Alligator’s CEO on current development and the rights issue
21 March, 2024
Clinical effects observed with Alligator’s 4-1BB agonist
14 March, 2024
Alligator prepares for phase III with CD40 agonist
20 February, 2024
Alligator’s CEO comments on restructuring plan
16 February, 2024
Alligator meets primary endpoint with CD40 agonist in pancreatic cancer
31 January, 2024
Alligator granted US patent for cancer therapy platform
22 January, 2024
Alligator showcases bold drug development vision
8 December, 2023
Strong Q3 performance for Alligator Bioscience
2 November, 2023
Alligator’s CEO: trust is a key to success
12 October, 2023
Data backs up anti-tumour effect of Alligator’s lead asset
5 October, 2023
Alligator Bioscience expands orphan designation to Europe
30 August, 2023
Alligator Bioscience’s CSO presents CD40 portfolio at summit
14 July, 2023
Phase II results indicate durability of response for Alligator’s CD40 agonist
30 June, 2023
Alligator Bioscience awarded Orphan Drug Designation for mitazalimab
25 May, 2023
Alligator Bioscience’s CEO on the rights issue
8 May, 2023
Alligator gearing up for new milestones with mitazalimab
5 May, 2023
BioStock Investor Pitch: Alligator Bioscience
4 May, 2023
Alligator’s CEO on current development and the rights issue
3 May, 2023
FDA approves Alligator’s phase II trial
11 April, 2023
Alligator’s CMO hosts in-depth webinar on Mitazalimab
28 March, 2023
Alligator Bioscience extends collaboration with Orion Corporation
11 January, 2023
Alligator Bioscience presents positive interim data
3 January, 2023
Watch the BioStock Life Science Fall Summit!
8 December, 2022
Alligator Bioscience’s Q3 is out – comments from the CEO
25 October, 2022
Evaxion brings in Per Norlén as CEO
21 October, 2022
Erika Samuelsson new CDO at Cyxone
22 September, 2022
Green light for Alligator Bioscience and Aptevo Therapeutics
21 September, 2022
BioStock Life Science Fall Summit 2022
16 August, 2022
Alligator Bioscience’s new CMO
7 July, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
BioStock Studio: Alligator Bioscience’s CEO on the latest data
24 March, 2022
Allegro Investment Fund on the ownership in Alligator Bioscience
9 March, 2022
Alligator Bioscience on the latest developments
25 January, 2022
Join us for the BioStock Life Science Summit on October 20...
20 October, 2021
Alligator starts phase II and raises capital
11 October, 2021
BioStock Studio: Alligator Bioscience’s long-term value driver
7 October, 2021
Positive outcome for Alligator Bioscience’s joint study with Scandion Oncology
10 September, 2021
Targinta’s new CEO has started
3 September, 2021
Alligator Bioscience enters collaboration with Orion Corporation
19 August, 2021
Key advancements for Alligator Bioscience in Q2
13 July, 2021
BioStock Studio: Scandion Oncology and Alligator Bioscience forge preclinical collaboration
4 July, 2021
Strong first half of 2020 for Scandion Oncology
4 July, 2021
First impressions from Alligator’s new CEO
1 July, 2021
Innovation in focus at BioStock Life Science Spring Summit 2021
25 May, 2021
1
2
Page 1 of 2
